negligible by using a parametric bootstrap procedure. We propose an efficient algorithm for maximizing the h-likelihood. A simulation study, based on a classical HIV dynamical model, confirms the good properties of the MHLE. We apply it to the analysis of a clinical trial.
INTRODUCTION
Since the influential paper of Ho et al. (1995) there has been a strong impetus to develop mathematical models for better understanding the interaction between HIV and the immune system; see Nowak and May (2000) .
However the statistical inference in these models has raised major challenges coming from the intrication of identifiability and numerical problems. The first problem is numerical: in general the trajectories of the interesting quantities (e.g. viral load or CD4 counts) are solutions of non-linear differential equations that do not have analytical solutions. The second problem is the identifiability problem: the observations recorded on one subject are not informative enough to estimate all the parameters of the model. The first problem is either avoided, simplifying the models to obtain analytical solutions (Wu and Ding, 1999) , or solved by using numerical solvers of ordinary differential equations (ODE); Ramsay et al. (2007) proposed an original approach but did not apply it to a random effect model. The second problem is partly treated by considering that the particular values of the pa-rameters for each subject are realizations of random variables with a given distribution in the population. This puts the problem in the framework of non-linear mixed effects models. Laplace approximation of the numerical integrals involved in the computation of the likelihood has been proposed (Beal and Sheiner, 1982; Lindstrom and Bates, 1990) ; adaptive Gaussian quadrature is another possibility (see Davidian and Giltinan, 1995) . We refer to Wu (2005) for a review of statistical issues in HIV models. Recently a stochastic approximation EM (SAEM) algorithm has been proposed (Kuhn and Lavielle, 2005; Donnet and Samson, 2007) . In the specific case of HIV dynamics models a Bayesian approach has been proposed by Putter et al. (2002) and Huang, Liu and Wu (2006) , while a special algorithm for computing the likelihood and maximizing using a Newton-like method has been proposed by Guedj, Thiébaut and Commenges (2007) . However all these methods present difficulties and can be time-consuming.
The hierarchical likelihood (h-likelihood) has been proposed for generalized linear models with random effects by Lee and Nelder (1996) and further studied in Lee and Nelder (2001) and Lee, Pawitan and Nelder (2006) and for non-linear mixed effects models by Noh and Lee (2008) . This is very similar to an approach called penalized likelihood used by McGilChrist and Aisbett (1991) and Therneau and Grambsch (2000) for frailty models. The main idea is to treat the random effects (or the frailties) as parameters and to find estimates of all the parameters by maximizing a function which is essentially the loglikelihood conditional on the random effects minus a penalty term which takes large values if the "random" parameters are very dispersed. Penalized likelihood has also been used for function estimation (O'Sullivan; 1988) . The advantage of this approach is that it may avoid computing numerical integrals. The curse of dimensionality is transferred from the dimension of numerical integrals to the dimension of the space on which maximization takes place. There are problems with this approach.
One is the asymptotic distribution of the estimators of the fixed parameters; another is the estimation of the variances of the random parameters.
Consistency of the maximum h-likelihood estimators (MHLE) has not been proved. It is often suggested to revert to the likelihood to have consistent estimators of the fixed parameters, but then the most important benefits of h-likelihood in terms of computational burden is lost. Last but not least is the problem of maximizing a complicated function over several hundred parameters.
The aim of this paper is to develop a (partly non-standard) h-likelihood approach to HIV dynamics models which completely avoids computation of the likelihood. This is in the spirit of penalized likelihood in the sense that we do not try to precisely estimate the variances of the random effects. One aim is to study the asymptotic distribution of the MHLE for a given choice of the penalty. Another aim is to find an efficient maximization algorithm.
The paper is organized as follows. In section 2 we describe a statistical model based on an ODE system in a general form and in a particular form which will be used for simulations. In section 3 we describe h-likelihood and we give the asymptotic distribution of the MHLE for fixed effects when the number of subjects tends toward infinity. We propose a parametric bootstrap procedure to correct the bias of the MHLE. In section 4 we propose a strategy for choosing the penalty based on the guess of an upper bound of the variance of the random effects. An efficient maximization algorithm is presented in section 5. Section 6 presents a simulation study. Section 7 presents the analysis of a clinical trial. We conclude in section 8.
A POPULATION DYNAMICS MODEL

A general model for the system
The dynamics of the concentrations of virions and CD4+ T-cells (in short, CD4) in different stages (represented by X i (t)) can be described by an ODE system. We allow the values of the parameters to vary between subjects; thus we consider a population model, as in Guedj, Thiébaut and Commenges (2007) . For subject i with i = 1, ...n, this can be written:
where 
where φ l is the intercept, z i l (t) are vectors of explanatory variables associated with the fixed effects of the lth biological parameter; these explanatory variables may be time-dependent, in which case the ODE system has time-dependent parameters. The β l 's are vectors of regression coefficients;
is the individual vector of random effects. We assume b i ∼ N (0, Σ) with Σ diagonal with diagonal elements τ 2 l . More general models could of course be considered.
Model for the observations
Let Y ijm denote the jth measurement of the mth observable component for subject i at time t ijm ; we assume that: 
A particular model for HIV dynamics
For illustrating the proposed method we present a version of a rather standard model for the HIV dynamics model, close to that used by Nowak and Bangham (1996) :
where T i , T * i represent the concentrations (implicitly depending on t) of non-infected and infected CD4 respectively, and V i stands for the concentration of virus.
Here the components of ξ 
where z i 1 (t) and z i 2 (t) are treatment indicators. The treatment may change with time; here we will suppose that they are fixed for t ≥ 0 but take the value 0 for t < 0. We assume that at t = 0 the patients are at the equilibrium of the system with z i 1 (t) = z i 2 (t) = 0 and this gives important information. As for the observation equation (3) we will take in the simulations: h-loglikelihood:
is the loglikelihood (normalized by 1 n ) for the observation conditional on b, and J(
values which maximize HL(θ, b, τ ) for given τ ;θ τ will be called the MHLE of the parameters θ. We have HL(θ,
for subject i conditional on b i . For simpler notation we will not always make the dependence in τ explicit and will write for instance HL(θ, b) for HL(θ, b, τ ). We shall make the additional assumptions: A1 l(y; θ, b i ) and J(b i ; τ ) are continuous and twice-continuously differentiable functions of θ and b i for all y and τ ;
We shall derive asymptotic results for the MHLE of the fixed parameters θ, which do not require that τ = τ * .
Lemma 1 Under assumptions A1 and A2 the MHLE for fixed effects are M-estimators.
Proof. Consider the profile h-loglikelihood PHL n (θ) = HL(θ,b(θ)), wherê For the convergence result we need the additional assumption: A3 For every sufficiently small ball U ∈ Θ, E P * sup θ∈U hl(y; θ, b(y; θ)) < ∞.
In the convergence theorems of the MHLE we will emphasize the fact that it depends on n by writingθ τ =θ τ n .
Theorem 1 If Θ is compact and assumption A1-A3 holds, the MHLE of fixed effectsθ τ n converges in probability toward
Proof. By the law of large numbers
Let us call θ τ 0 the value, that we assume unique, at which M (θ) attains its maximum. The conditions stated in the Theorem, together with the continuity assumption A1, allow us to apply Wald's consistency proof (van der Vaart, 1998, Theorem 5.14, p48).
Corollary 1 The MHLE of the fixed parameter of the statistical model described in section 2 converges in probability toward
Proof. In the case of the statistical model of section 2 we have hl(
is the solution of the ODE system with parameters θ, b i ). In case where σ 2 m are fixed, assumption A3 is trivially satisfied because we can remove the terms involving σ 2 m and obtain a function which is bounded by zero. If we include the σ 2 m in the parameters that we wish to estimate, assumption A3 is satisfied since hl(
. It seems reasonable to conjecture that The asymptotic normal distribution holds for M-estimators under some regularity conditions. We make use of Theorem 5.23 of van der Vaart (1998) which only requires a Lipshitz condition on m θ (y) = hl(y; θ, b(y; θ)) that we can establish if the following assumption bearing on u θ (y) = ∂hl(y;θ,b(y;θ)) ∂θ holds. We shall use u θ i = u θ (Y i ) and will give an alternative expression in formula (6).
A4
There is a neighborhood Θ 0 ⊂ Θ of θ τ 0 such that the functionṁ(y) = sup θ∈Θ 0 u θ (y) has the property:
Theorem 2 Assume assumptions A1-A4 hold. Then √ n(θ τ n −θ τ 0 ) is asymptotically normal with zero expectation and variance equal to
where
Proof. The theorem follows by applying Theorem 5.23 of van der Vaart (1998). In this theorem, the main condition is that there exists a measurable functionṁ with E P * ṁ 2 < ∞ such that for every θ 1 and θ 2 in a neighborhood Θ 0 of θ 0 we have:
A Taylor series expansion gives:
T ∂m θ ∂θ (θ), wherẽ θ ∈ Θ 0 . This yields:
Then assumption A4 allows us applying the Theorem 5.23 of van der Vaart (1998).
For applying Theorem 2, it remains to compute the first and second derivatives of m θ (Y i ) in terms of derivatives of the likelihood conditional on the random effects. We write 
Hence we obtain that
That is u θ i is simply the derivative of the loglikelihood as if b was fixed, computed in (θ,b i (θ)). (5) wrt θ we have:
Next we have H
from which we obtain:
Hence:
In practice we can plug in the estimatorθ τ to obtain an estimator of Σ(θ τ 0 ) (using the continuous mapping theorem). We may also use the observed scores and Hessian. By virtue of the law of large numbers they converge toward their expectations, and again the continuous mapping theorem allows to prove consistency of the resulting estimator.
Correction of the bias
We have shown in section 3.2 that the MHLEθ τ tends toward θ τ 0 which is in general different from θ * ; thus there is an asymptotic bias θ τ 0 − θ * .
Note that the asymptotic distribution is valid for any τ , and on the other hand,θ τ is biased even for τ = τ * . Thus the problem of this approach is essentially that of the bias, although a small bias may be acceptable if it goes with a small variance. We propose to partially correct the bias by parametric bootstrap (Efron and Tibshirani, 1993).
Specifically, for s = 1, . . . , S, generate the b
; compute the MHLEθ τ ,s for these data. An estimator of the bias is S −1 S s=1 (θ τ ,s −θ τ ). Thus the corrected estimator, called cMHLE, isθ
This correction slightly increases the variance. The variance ofθ τ can be computed through the formula var E P * (θ τ |θ τ )+E P * var(θ τ |θ τ ). Neglecting the bias of the MHLE in this computation we obtain:
PENALTY CHOICE
Profile likelihood has been proposed by Therneau and Grambsch (2000) and Lee and Nelder (2001) but it has the drawback of requiring the computation of the marginal likelihood. We propose a strategy for penalty choice which avoids this computation. For any choice of τ = (τ 1 , . . . , τ R ) we have that θ τ has an asymptotic normal distribution with expectation θ τ 0 and with a variance that can be estimated. We propose to take a reasonable upper bound of τ , that is, the value τ u = (τ u , . . . , τ u ) where τ u is considered as an approximate upper bound for the τ * i . First, note that since we are working with natural logarithms of the biological parameters, the τ i may be interpreted as coefficients of variation of these parameters. It seems reasonable (and is in agreement with the literature) to expect coefficients of variations of parameters such as rate of production of new lymphocytes (λ) or death rate of uninfected lymphocytes (µ T ) are not very large, that is no more than 0.3.
MAXIMIZATION ALGORITHM
Newton-like algorithms use an approximation of the Hessian of the function to maximize. Since there are many parameters, this matrix can be very large. For instance in our application q = 7, R = 3, n = 100, so the number of parameters is q + nR = 307. In complex problems, both gradient and Hessian have to be computed numerically. Particular care must be spent to compute the Hessian both economically and precisely. The algorithm we propose is an adaptation of the Marquardt algorithm (Marquardt, 1963) , taking advantage of the special structure of the Hessian in our problem. We draw two consequences of this special structure: (i) there are many terms which are equal to zero, so we do not need to compute them; (ii) the matrix is not far from being block-diagonal.
We shall first consider the particular case where the number of random and fixed effects are equal (R = q) and the loglikelihood of subject i, l(Y i ; θ, b i ), depends only on θ + b i . We are interested in maximizing the following function:
It is useful to reparametrize in term of a i = θ + b i . One finds
With this parameterization the loglikelihood, l
, which is the complex part, depends only on a i so that many derivatives of the h-loglikelihood are very simple: Step 1: For i = 1, . . . , n: make one Marquardt step for optimizing the function l
on a i ; this gives a i (k + 1);
Step 2: compute
r (k + 1) (which satisfies (7)); go to step 1 (until convergence is reached).
The patient-by-patient algorithm works very well far from the maximum when the global Marquardt algorithm is hampered by the need of a large increase of the diagonal of the Hessian. However the decoupling between patients also leads to a loss of efficiency so that close to the maximum it is less efficient than the global Marquardt algorithm. This observation led us to devise a hybrid algorithm: use the patient-by-patient algorithm until all blocks C i are definite-positive; then switch to the global Marquardt algorithm. Note that ensuring that all blocks C i be definite-positive does not imply that the Hessian is so; generally however it is not far from being the case so that the Marquardt algorithm is efficient.
We now consider the case where there are R fixed parameters, that we call α, associated with a random effect; such as above the loglikelihood of subject i, l(Y i ; θ, b i ), depends only on α+b i and a vector of fixed parameters β. As in the preceding case, the Hessian has a particular structure (see We did simulations from the model described in section 2.3. We fixed (that is we did not estimate) the parametersμ V ,μ T and σ i , at values which are plausible in view of the literature (taking as time unit the day and as volume unit the micro-liter):μ V = 3.40;μ T = −2.20; σ i = 0.5, i = 1, 2, 3. The values for the other parameters (to be estimated), including the two treatment effects β 1 and β 2 , are given in Table 2 . For each replica, observations for n = 100 subjects were generated; for each subject n im = 10 observations for the three compartments (m = 1, 2, 3) were generated at times 0, 3, 6, 9, 12, 15, 18, 21, 24, 30. 
Efficiency of the algorithm
We did a simulation to compare the number of iterations of the global Marquardt algorithm and the hybrid algorithm. We tried the two algorithms with models including one to three random effects. The initial values were: λ = 5.0;μ T * = 0;π = 0;γ 0 = −5.0; β 1 = −1.0; β 2 = −1.0. The global Marquardt algorithm did not always converge in less than 150 iterations while the hybrid algorithm nearly always converged (see Table 1 ); when they both converged, this was toward the same values (close to the true parameter values). We checked that when we started from different values the algorithms converged toward the same values. The hybrid algorithm is faster than the global one. In Table 1 we give the mean number of iterations 
Efficiency of the bias correction
We estimated the bias of the correctedθ τ and uncorrected MHLEθ τ using 500 replicas of a distribution with three random effects bearing onλ,μ T * ,π.
We first examine the case where τ = τ * = (0.2, 0.2, 0.2). The biases of the uncorrected MHLE are of order 10 −2 for all parameters. The correction reduces the biases to the order of 10 −3 (except for one parameter), which seems negligible. 
Property of the cMHLE
We wished to check whether the asymptotic results hold in practice. We simulated data from the standard model of section 2.3. In the first simulation (case 1) we took as standard deviations of the random effects τ * Table 3 . In the first case, the results tend to be better when τ u = 0.2 which is closer to the τ * r , while τ u = 0.3 tends to be better than τ u = 0.1. For the second case the results for τ u = 0.2 and τ u = 0.3 were approximately of the same quality, better than for τ u = 0.1. It is striking that most of the RMSE are roughly of the same order, between 10 −2 and 10 −1 . These RMSE can be interpreted as typical relative errors on the natural parameter; in these simulation the order of magnitude is about 5%.
In term of coverage rates, the results (see Table 4 ) are not very good for τ u = 0.1. They are satisfactory for τ u = 0.2 , and even more satisfactory for τ u = 0.3. This corroborates our strategy based on a reasonable upper bound τ u of the τ * r . 
APPLICATION TO A CLINICAL TRIAL
As an application of the proposed method, we aimed at estimating the difference of treatment effects in a randomized clinical trial (Molina et al., 1999) . The ALBI ANRS 070 trial compared over 24 weeks the combination of zidovudine plus lamivudine (AZT+3TC) with that of stavudine plus didanosine (ddI+d4T) (a third arm alternating from one regimen to another was not considered in this paper). The inclusion criteria were CD4 ≥ 200 cells/µL and HIV RNA level between 4 and 5 log 10 copies/mL within 15 days before entry into the study. The primary outcome measure defined in the study protocol was the antiretroviral effect as measured by the mean change in HIV RNA level between baseline and 24 weeks by use of the ultra-sensitive PCR assay with lower limit of quantification of 50 copies/mL (1.7 log 10 ). In the main analysis of Molina et al. (1999) , HIV RNA values reported as < 50 copies/mL were considered equivalent to 50 copies/mL; 51 patients were included in each treatment group. Over the 24-week period, HIV RNA level declined in the two groups, with mean (SE) decreases at the end of the study of 1.26 (0.09) log 10 copies/mL in the AZT+3TC group and 2.26 (0.11) log 10 copies/mL in the ddI+d4T group. We used the model described in section 2. We foundη = 0.242, varη = 5.16 10 −3 ; this gives W = 3.37 and a p-value equal to p = 7 10 −4 . Thus we conclude as expected that the treatment groups differ, and more precisely that the infectivity of the virus has been reduced more drastically in the ddI+d4T than in AZT+3TC group.
Baseline infectivity is multiplied by a factor estimated to eβ 2 = 0.25 and eβ 1 = 0.32 in the ddI+d4T than in AZT+3TC groups respectively. 
CONCLUSION
We have developed a hierarchical likelihood approach for inference in an HIV dynamical model. We have obtained the asymptotic distribution of the MHLE, we have derived a procedure which makes the bias negligible and we have developed an efficient maximization algorithm. Our simulations show that the whole approach works.
We have shown that it could be applied to the analysis of a real data set. Rather precise estimates of the parameters were obtained. One limitation of this approach is that some parameters must be fixed because of identifiability problems. The model itself, although it is already statistically challenging, may be too simple from a biological point of view. The development of such an approach would require richer data, for instance observing the number of infected T cells.
The main advantage of this approach is that it is easy to implement and very fast as compared to the two main competing approaches, likelihood and Bayesian inference. The main limitation is that it does not attempt to estimate the variances of the random effects. In our application we already have a knowledge of the range of values of these variances. Thus the method can be used for exploring possible models while likelihood or Bayesian inference can be used when estimates of the variances of the random effects are needed.
